Abstract:Cocrystallization of racemic-compound-forming chiral molecules can result in conglomerate cocrystals or diastereomerically related cocrystals, which enable the application of chiral separation techniques such as preferential crystallization and classic resolution. Here, a systematic method to identify the types and phase diagrams of cocrystals formed by chiral target compounds and candidate coformers in a particular solvent system is presented, which allows the design of suitable chiral resolution processes. The method is based on saturation temperature measurements of specific solution compositions containing both enantiomers of chiral molecules and a coformer. This method is applied to analyze three different systems. For racemic phenylalanine (Phe) in water/ethanol mixtures one of the enantiomers selectively cocrystallizes with the opposite enantiomer of valine (Val), forming the more stable diastereomerically related cocrystal. The racemic compound ibuprofen crystallizes with the nonchiral coformer 1,2-bis(4-pyridyl)ethane (BPN) as racemic compound cocrystals. More interestingly, when it is combined with <i>trans</i>-1-(2-pyridyl)-2-(4-pyridyl)ethylene (BPE), the racemic compound ibuprofen cocrystallizes as a conglomerate, which in principle enables the application of preferential crystallization of this racemic compound. The systematic method shows the benefit of using pseudo-binary phase diagrams. Such pseudo-binary phase diagrams depict the saturation temperature on a very specific route through the quaternary phase diagram, allowing the identification of various cocrystal types as well as the corresponding cocrystallization conditions. The systematic method can be used to identify a suitable solid phase for chiral separation, and the obtained phase diagram information enables the performance of a crystallization-mediated chiral resolution process design. Such a guideline for a chiral resolution process design has never been reported for conglomerate cocrystal systems such as IBU:BPE, presented in this study.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.cgd.0c00890?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.cgd.0c00890</a>.XRPD diffractograms of all relevant crystalline products from the present study (<a class="ext-link" href="/doi/suppl/10.1021/acs.cgd.0c00890/suppl_file/cg0c00890_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Solid Phase Behavior, Polymorphism, and Crystal Structure Features of Chiral Drug Metaxalone

The Polymorphic Drug Substances of the European Pharmacopoeia. Part 9. Physicochemical Properties and Crystal Structure of Acetazolamide Crystal Forms

Distinguishing Polymorphs of Ethenzamide-Saccharin Cocrystal Based on Terahertz and Raman Vibrational Spectroscopic Techniques

Properties of the racemic species of verapamil hydrochloride and gallopamil hydrochloride

Solid Forms and β-Cyclodextrin Complexation of Oxymetholone and Crystal Structure of Metribolone

Understanding complex phase transition mechanism by crystal structure analysis

Chloral Hydrate Polymorphs and Cocrystal Revisited: Solving Two Pharmaceutical Cold Cases

Thermodynamic Investigation of Carbamazepine-Saccharin Co-Crystal Polymorphs

Rare Case of Polymorphism in the Binary System of Enantiomers of a Praziquantel Derivative

Screening Approach for Identifying Cocrystal Types and Resolution Opportunities in Complex Chiral Multicomponent Systems

Investigating Differences and Similarities between Betaxolol Polymorphs

Polymorphism in S(+)Clopidogrel-Picrate: Insights from X-ray Diffraction, Vibrational Spectroscopy, Thermal Analysis, and Quantum Chemistry

Crystal structure, packing features, DFT evaluation of intermolecular hydrogen bonds, and crystal lattice energy of a polymorph of 4-oxo-4-phenylbutanoic acid

Fundamental theoretical and practical investigations of the polymorph formation of small amphiphilic molecules, their co-crystals and salts

Understanding the Polymorphic Behavior of Sibenadet Hydrochloride through Detailed Studies Integrating Structural and Dynamical Assessment

Metronidazole Cocrystal Polymorphs with Gallic and Gentisic Acid Accessed through Slurry, Atomization Techniques, and Thermal Methods

Combined X-ray Crystallographic, IR/Raman Spectroscopic, and Periodic DFT Investigations of New Multicomponent Crystalline Forms of Anthelmintic Drugs: A Case Study of Carbendazim Maleate

Crystal polymorphism and spectroscopical properties of sulfonamides in solid state by means of First Principles calculations

Thermal analysis assisted by spectra-structure studies of BCS class II active pharmaceutical ingredients: ezetimibe and lercanidipine hydrochloride. The concept of preformulation

Pharmaceutical properties of two ethenzamide-gentisic acid cocrystal polymorphs: Drug release profiles, spectroscopic studies and theoretical calculations

Enantiotropy of Simvastatin as a Result of Weakened Interactions in the Crystal Lattice: Entropy-Driven Double Transitions and the Transient Modulated Phase as Seen by Solid-State NMR Spectroscopy